Mediterr J Rheumatol 2019;30(Supp 1):63-8
The role of the Nocebo effect in the use of biosimilars in routine rheumatology clinical practice
Authors Information
1First Department of Propaedeutic Internal Medicine, Joint Rheumatology Program, National & Kapodistrian University
of Athens Medical School, Athens, Greece
2Clinical Research Unit, Dudley Group NHS Foundation Trust, Dudley, UK,
3Arthritis Research UK Centre for Epidemiology, University of Manchester, Manchester, UK
This paper has no abstract.